Just one day after its IPO, Anthropic (ANT) shares came under heavy selling pressure.
Morgan Stanley and the underwriting banks exercised the full Greenshoe option, covering 147 million additional shares, worth approximately 12.2 billion USD at 83 USD per share.
ANT price performance:
From an IPO price of 83 USD, ANT opened at 111.50 USD, closed its first trading session at 97.17 USD, and briefly fell to 85 USD during the November 20 session.
Observations:
Weaker technical price support: The Greenshoe option has been fully exercised, meaning the source of buying support from the underwriters’ price-stabilisation activity is no longer available to the same extent.
Valuation under pressure: From 111.50 USD down to nearly 85 USD, ANT is showing the gap between initial IPO expectations and the price the market is actually willing to accept.
Growth does not necessarily mean profitability: Revenue is growing strongly, but AI infrastructure costs and computing capacity remain major challenges.
Key price levels:
92–97 USD: Resistance, a zone where a recovery could be confirmed.
85–92 USD: Consolidation and sideways trading range.
83–85 USD: Important support, close to the IPO price.
This suggests that ANT may still face further downward pressure. I am not rushing to buy the dip until buying demand is confirmed.
Because a good company does not necessarily mean its stock is always available at a good price.
Will 83 USD become ANT’s bottom, or is it just a stopping point before another deeper decline?
#anthropicplungestowardipopriceonday2 .
This analysis is for reference only and is not investment advice.
